The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

Data Availability
All data are included in the manuscript
Posted July 14, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (734)
- Anesthesia (215)
- Cardiovascular Medicine (3146)
- Dermatology (267)
- Emergency Medicine (467)
- Epidemiology (13112)
- Forensic Medicine (15)
- Gastroenterology (875)
- Genetic and Genomic Medicine (4933)
- Geriatric Medicine (455)
- Health Economics (758)
- Health Informatics (3107)
- Health Policy (1110)
- Hematology (414)
- HIV/AIDS (980)
- Medical Education (460)
- Medical Ethics (121)
- Nephrology (508)
- Neurology (4688)
- Nursing (248)
- Nutrition (694)
- Oncology (2418)
- Ophthalmology (688)
- Orthopedics (270)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1256)
- Primary Care Research (527)
- Public and Global Health (7251)
- Radiology and Imaging (1622)
- Respiratory Medicine (950)
- Rheumatology (463)
- Sports Medicine (407)
- Surgery (524)
- Toxicology (65)
- Transplantation (223)
- Urology (193)